000 01232nam  2200301za 4500
0019.839121
003CaOODSP
00520221107151534
007cr |||||||||||
008170629s2017    onc     o    f000 0 eng d
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-13/2017-3E-PDF
24500|aAcute dermal toxicity study waiver |h[electronic resource].
260 |aOttawa : |bHealth Canada, Pest Management Regulatory Agency, |c2017.
300 |a5 p.
4901 |aScience policy note, |x2368-1861 ; |vSPN2017-03
500 |aIssued also in French under title: Exemption concernant les études de toxicité aiguë par voie cutanée.
500 |aCover title.
500 |a"26 June 2017."
504 |aIncludes bibliographical references.
69207|2gccst|aToxicology
69207|2gccst|aHealth impact
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tExemption concernant les études de toxicité aiguë par voie cutanée |w(CaOODSP)9.839122
830#0|aScience policy notices,|x2368-1861 ; |vSPN2017-03|w(CaOODSP)9.504452
85640|qPDF|s160 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-13/H113-13-2017-3-eng.pdf